1. Home
  2. ADIL vs GIPR Comparison

ADIL vs GIPR Comparison

Compare ADIL & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADIL
  • GIPR
  • Stock Information
  • Founded
  • ADIL 2010
  • GIPR 2015
  • Country
  • ADIL United States
  • GIPR United States
  • Employees
  • ADIL N/A
  • GIPR N/A
  • Industry
  • ADIL Biotechnology: Pharmaceutical Preparations
  • GIPR Real Estate Investment Trusts
  • Sector
  • ADIL Health Care
  • GIPR Real Estate
  • Exchange
  • ADIL Nasdaq
  • GIPR Nasdaq
  • Market Cap
  • ADIL 7.6M
  • GIPR 5.3M
  • IPO Year
  • ADIL 2018
  • GIPR 2021
  • Fundamental
  • Price
  • ADIL $0.38
  • GIPR $0.84
  • Analyst Decision
  • ADIL Strong Buy
  • GIPR
  • Analyst Count
  • ADIL 1
  • GIPR 0
  • Target Price
  • ADIL $8.00
  • GIPR N/A
  • AVG Volume (30 Days)
  • ADIL 4.2M
  • GIPR 55.3K
  • Earning Date
  • ADIL 08-19-2025
  • GIPR 08-18-2025
  • Dividend Yield
  • ADIL N/A
  • GIPR N/A
  • EPS Growth
  • ADIL N/A
  • GIPR N/A
  • EPS
  • ADIL N/A
  • GIPR N/A
  • Revenue
  • ADIL N/A
  • GIPR $9,711,058.00
  • Revenue This Year
  • ADIL N/A
  • GIPR N/A
  • Revenue Next Year
  • ADIL N/A
  • GIPR N/A
  • P/E Ratio
  • ADIL N/A
  • GIPR N/A
  • Revenue Growth
  • ADIL N/A
  • GIPR 11.25
  • 52 Week Low
  • ADIL $0.22
  • GIPR $0.80
  • 52 Week High
  • ADIL $1.30
  • GIPR $2.71
  • Technical
  • Relative Strength Index (RSI)
  • ADIL 43.03
  • GIPR 19.08
  • Support Level
  • ADIL $0.39
  • GIPR $1.36
  • Resistance Level
  • ADIL $0.46
  • GIPR $1.57
  • Average True Range (ATR)
  • ADIL 0.08
  • GIPR 0.11
  • MACD
  • ADIL -0.01
  • GIPR -0.06
  • Stochastic Oscillator
  • ADIL 7.29
  • GIPR 3.73

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.

Share on Social Networks: